IHH healthcare Q1 net profit falls to RM514mil
KUALA LUMPUR: IHH Healthcare Bhd has recorded a drop in net profit to RM514 million in the first quarter of its financial year ending Dec 31, 2025 (1Q FY2025) from RM768 million in 1Q FY2024.
Revenue for the quarter under review rose to RM6.29 billion from RM5.96 billion last year, due to gains in the hospital and healthcare segments and Parkway Life REIT (PLife REIT), the company said in a filing with Bursa Malaysia.
"Hospital and healthcare revenue in 1Q FY2025 increased by 7.0 per cent to RM6.05 billion, driven by sustained demand for quality healthcare services, a case-mix of more acute patients, and price adjustments to counter inflation.
"The consolidation of Island Hospital, which was acquired in November 2024, also contributed to the increase in revenue," it said.
IHH Healthcare added that PLife REIT's external revenue for 1Q FY2025 rose 15 per cent to RM45 million, driven by contributions from the 11 nursing home properties in France acquired in December 2024.
The company remains in a strong position, given its track record in delivering high-quality and cost-effective healthcare.
By leveraging operational synergies across its international network, IHH Healthcare remains confident in its ability to maintain cost efficiency while upholding its commitment to value-based healthcare.
"Despite global economic and geopolitical headwinds, the group remains well poised to navigate uncertainties, underpinned by strong fundamentals, strategic growth initiatives, and long-term healthcare megatrends," it said
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Barnama
4 days ago
- Barnama
IHH Healthcare Shares Down After Posting Lower First Quarter Net Profit
BUSINESS KUALA LUMPUR, May 30 (Bernama) -- IHH Healthcare Bhd shares fell in the mid-morning trading session after the hospital operator posted a lower net profit in the first quarter of its 2025 financial year (1Q FY2025). At 10.58 am, IHH dropped six sen to RM6.85, with 2.23 million shares changing hands. IHH's net profit fell to RM514 million in 1Q FY2025 from RM768 million in 1Q FY2024, while revenue rose to RM6.29 billion from RM5.96 billion. The improved revenue was due to gains in the hospital and healthcare segments, as well as Parkway Life REIT (PLife REIT), the company stated. Public Investment Bank Bhd (Public IB) and Hong Leong Investment Bank Bhd (HLIB) said IHH's first quarter results were in line with both their expectations and those of the market, and they have maintained their earnings forecasts for the healthcare provider for the fiscal years 2025 and 2026. Public IB said IHH's capacity expansion plans remain firmly on track, with a targeted increase of over 30 per cent in bed capacity to nearly 4,000 beds by 2028, with about 1,000 beds added in FY2024. In 1Q FY2025, it noted that IHH expanded its footprint with the opening of the 127-bed Acibadem Kartal Hospital in Turkey and is on track to complete the acquisition of the 228-bed Shrimann Superspeciality Hospital in India by FY2025. Additionally, bed capacity at the Mount Elizabeth Orchard Hospital in Singapore is gradually being restored as part of a three-year renovation project scheduled for completion in 2025. 'Despite headwinds, particularly from rising operating and energy costs, we believe the resilient demand for quality healthcare services, supported by IHH's strong fundamentals and focused strategic initiatives, positions it well to deliver sustainable growth amid global macroeconomic uncertainties. 'We reiterate our outperform call on IHH with an unchanged sum-of-the-parts-based target price (TP) of RM8.64,' it added.
The Star
4 days ago
- The Star
IHH revenue grows to RM6.29bil in 1Q25
PETALING JAYA: IHH Healthcare Bhd will be forging ahead with its expansion and growth strategies to meet the increasing demand for quality healthcare services locally and across the region. Following the acquisitions of Timberland Medical Centre in Sarawak and Island Hospital in Penang in 2024, the group said in a Bursa Malaysia filing that it had opened the 127-bed Acibadem Kartal Hospital in Turkiye in the first quarter ended March 31, 2025 (1Q25) and expects to complete the acquisition of the 228-bedded Shrimann Superspeciality Hospital in India during the year. For 1Q25, IHH's net profit dropped to RM514mil from RM768mil in the previous corresponding quarter, while revenue grew to RM6.29bil from RM5.96bil a year earlier. 'The growth in revenue was driven by a sustained demand for quality healthcare services, a case-mix of more acute patients and price adjustments to counter inflation. 'The consolidation of Island Hospital, which was acquired in November 2024, also contributed to the increase in revenue.' IHH said its Singapore hospital inpatient admissions decreased 6% to 14,493 in 1Q25 while its revenue per inpatient admission increased 10% to RM67,294. 'Malaysia's hospital inpatient admissions increased 6% at 62,406 in 1Q25 while its revenue per inpatient admission increased 6% to RM11,334. 'India's hospital inpatient admissions increased 7% to 78,485 in 1Q25 while its revenue per inpatient admission increased 4% to RM10,152.' Meanwhile, Turkiye and Europe hospital inpatient admissions was flat at 66,776 in 1Q25 while its revenue per inpatient admission increased 16% to RM13,522 with price adjustments, especially in Turkiye, to counter hyperinflation. While the demand for quality healthcare remains robust, IHH said ongoing industry-wide challenges including rising cost pressures as well as higher energy costs and staff costs. 'In addition, payor pressures from both public and private insurers continue to shape reimbursement dynamics in the industry.' To unlock value from its key markets and to address the industry-wide challenges, IHH said it has embarked on a multi-year transformation initiative to drive continuous improvement through seven focus areas. The areas are clinical excellence, patient experience, new care models, operational excellence, payor and regulator engagement, employee and doctor value proposition, and the advancement of technology, data, and artificial intelligence. 'The group remains in a good position given its strong track record in delivering high-quality and cost-effective healthcare. 'By leveraging operational synergies across its international network, the group remains confident in its ability to maintain cost efficiency while upholding its commitment to value-based healthcare.' Despite global economic and geopolitical headwinds, IHH said it remains well-poised to navigate uncertainties, underpinned by strong fundamentals, strategic growth initiatives, and long-term healthcare megatrends.
New Straits Times
5 days ago
- New Straits Times
IHH healthcare Q1 net profit falls to RM514mil
KUALA LUMPUR: IHH Healthcare Bhd has recorded a drop in net profit to RM514 million in the first quarter of its financial year ending Dec 31, 2025 (1Q FY2025) from RM768 million in 1Q FY2024. Revenue for the quarter under review rose to RM6.29 billion from RM5.96 billion last year, due to gains in the hospital and healthcare segments and Parkway Life REIT (PLife REIT), the company said in a filing with Bursa Malaysia. "Hospital and healthcare revenue in 1Q FY2025 increased by 7.0 per cent to RM6.05 billion, driven by sustained demand for quality healthcare services, a case-mix of more acute patients, and price adjustments to counter inflation. "The consolidation of Island Hospital, which was acquired in November 2024, also contributed to the increase in revenue," it said. IHH Healthcare added that PLife REIT's external revenue for 1Q FY2025 rose 15 per cent to RM45 million, driven by contributions from the 11 nursing home properties in France acquired in December 2024. The company remains in a strong position, given its track record in delivering high-quality and cost-effective healthcare. By leveraging operational synergies across its international network, IHH Healthcare remains confident in its ability to maintain cost efficiency while upholding its commitment to value-based healthcare. "Despite global economic and geopolitical headwinds, the group remains well poised to navigate uncertainties, underpinned by strong fundamentals, strategic growth initiatives, and long-term healthcare megatrends," it said
